NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · IEX Real-Time Price · USD
7.74
-0.22 (-2.76%)
Jul 22, 2024, 9:57 AM EDT - Market open
NeuroPace Employees
NeuroPace had 171 employees as of December 31, 2023. The number of employees increased by 4 or 2.40% compared to the previous year.
Employees
171
Change (1Y)
4
Growth (1Y)
2.40%
Revenue / Employee
$403,936
Profits / Employee
-$184,246
Market Cap
228.71M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 2seventy bio | 274 |
| Butterfly Network | 225 |
| Gossamer Bio | 135 |
| Semler Scientific | 92 |
| Acrivon Therapeutics | 61 |
| Design Therapeutics | 58 |
| Rezolute | 51 |
| ESSA Pharma | 50 |
NPCE News
- 2 months ago - NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 4 months ago - NeuroPace to Present at the Needham 23rd Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million - GlobeNewsWire
- 5 months ago - NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 - GlobeNewsWire
- 7 months ago - NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates - GlobeNewsWire
- 7 months ago - NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study - GlobeNewsWire
- 7 months ago - NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire